Corteva Inc. Common Stock vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Corteva Inc. Common Stock trades at $13.28 (market cap $9.17B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.96 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 2.8× Corteva Inc. Common Stock's market cap, and Corteva Inc. Common Stock pays the higher dividend (5.24%). Which is the better fit depends on your goals — on Pluang, investors hold Corteva Inc. Common Stock for 0 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| CTVA | RPRX | |
|---|---|---|
Market Cap | $9.17B | $25.27B |
Volume | 35,183,471 | 3,671,183 |
Sector | Basic Materials | Health |
52-Week High | $90.51 | $63.96 |
52-Week Low | $11.92 | $35.44 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $11.68B | $32.50B |
Dividend Yield | 5.24% | 1.66% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Corteva provides seeds, crop protection products, and digital tools for agriculture. Its products are used by farmers to manage crop production and protect yields.
Read more on CTVA →Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →